SPRO
Spero Therapeutics Inc
1.20$
-5.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 95.4% | 71.9% | 83.6% | 81.5% | 97.4% | 97.0% | 96.1% | 95.6% | 96.6% | 97.6% | 97.6% | 97.8% | |
| 87.6% | 41.9% | 49.1% | 42.4% | 56.4% | 47.8% | 62.9% | 50.2% | 89.7% | 58.4% | 95.1% | 96.2% | |
| 87.6% | 41.9% | 49.1% | 42.4% | 56.4% | 47.8% | 62.9% | 50.2% | 89.7% | 58.4% | 95.1% | 96.2% | |
| 2.8% | 27.8% | 32.3% | 33.9% | 39.4% | 47.5% | 31.2% | 39.4% | 4.5% | 36.8% | 0.1% | 0.0% | |
| – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 49.9% | 41.4% | 42.6% | 46.3% | 51.5% | 58.3% | 56.5% | 47.2% | 51.1% | 14.4% | 10.3% | 16.2% | |
| 23.8% | 20.4% | 24.9% | 30.4% | 36.3% | 44.4% | 37.5% | 24.1% | 25.2% | 12.9% | 9.3% | 16.0% | |
| 1.6% | 0.9% | 1.0% | 1.2% | 1.3% | 1.6% | 2.3% | 3.0% | 3.5% | 2.8% | 3.3% | 3.8% | |
| 1.0% | 0.8% | 1.8% | 1.8% | 4.5% | 6.6% | 2.3% | 1.3% | 2.6% | 1.0% | 0.4% | 0.3% | |
| 50.1% | 58.6% | 57.4% | 53.7% | 48.5% | 41.7% | 43.5% | 52.8% | 48.9% | 85.6% | 89.7% | 83.8% | |
| -412.9% | -214.4% | -240.7% | -281.3% | -324.6% | -415.8% | -609.3% | -765.0% | -890.9% | -654.5% | -776.5% | -886.6% | |
| 49.2% | 29.1% | 31.9% | 36.0% | 40.0% | 48.9% | 71.3% | 90.2% | 103.9% | 86.1% | 97.1% | 109.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.